Langerhans cell histiocytosis: Too many cytokines, not enough gene regulation?

Pediatric Blood and Cancer

Volumn 47, Issue 2, 2006, Pages 119-

  Aricò, Maurizio ^a  

^a Ospedale dei Bambini G Di Cristina   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

CLONAL VARIATION; GENE CLUSTER; GENE CONTROL; GENETIC PREDISPOSITION; HISTIOCYTOSIS X; HUMAN; IMMUNE RESPONSE; MEDICAL RESEARCH; PRIORITY JOURNAL; SHORT SURVEY; TUBERCULOSIS;

EID: 33745775862     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20748     Document Type: Short Survey

References (4)

1. Weitzman S, Egeler MR. Histiocytic disorders of children and adults: introduction to the problem, overview, historical perspective and epidemiology. In: Histiocytic disorders of children and adults. Cambridge, UK: Cambridge University Press, 2005, pp. 1-13.
2. Willman CL, Busque L, Griffith BB, et al. Langerhans'-cell histiocytosis (histiocytosis X)-A clonal proliferative disease. N Engl J Med 1994;331:154-160.
3. Arico M, Danesino C. Langerhans' cell histiocytosis: Is there a role for genetics? Haematologica 2001;86:1009-1014.
4. Annels NE, Da Costa CE, Prins FA, et al. Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis. J Exp Med 2003;197:1385-1390.